Assessing a New Treatment Approach for ADHD: Combining Herbal Syrup with Relaxation Techniques like shirodhara and shiropichu.

A Single Arm Open Label Clinical Trial To Evaluate The Efficacy Of Combined Therapy - Brahmyadi Syrup With Shirodhara And Shiropichu In The Management Of Attention-Deficit/Hyperactivity Disorder - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068680

Enrollment

Registered

2024-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Children of either sex in between age group of 5 to 10 years. Diagnosed case of ADHD. Children with average/normal IQ level (more than 90) Subjects satisfying DSM-5 criteria of diagnosis

Exclusion criteria

Exclusion criteria: Children with any known psychiatric illness and neurological disorder. Children with gross brain damage causing mental retardation Children with any genetic disorder Children with gross physical disability Children with any associated long term or fatal disease.

Design outcomes

Primary

Measure	Time frame
Change in the scoring/grading of symptom of ADHD on NICHQ Vanderbilt Assessment scale.Timepoint: Every 2 week of clinical trial. After 16 week of clinical trial completion.	—

Secondary

Measure	Time frame
Change in the quality of life by improvement in cognition & concentration with safe & effective treatment.Timepoint: Every 2 week of clinical trial. After 16 week of clinical trial completion.	—

Countries

India

Contacts

Public ContactDr Vishal prajapati

National institute of ayurveda jorawar singh gate jaipur

drrknagar@gmail.com9414062099

Outcome results